These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26786134)

  • 1. Chemically activatable viral capsid functionalized for cancer targeting.
    Chen CC; Xing L; Stark M; Ou T; Holla P; Xiao K; Kamita SG; Hammock BD; Lam K; Cheng RH
    Nanomedicine (Lond); 2016 Feb; 11(4):377-90. PubMed ID: 26786134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods.
    Chen CC; Stark M; Baikoghli M; Cheng RH
    J Vis Exp; 2018 May; (135):. PubMed ID: 29806824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs.
    Wang X; Zhao Q; Dang L; Sun Y; Gao J; Liu B; Syed SF; Tao H; Zhang G; Luo J; Zhou EM
    J Virol; 2015 May; 89(10):5491-501. PubMed ID: 25741007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface modulatable nanocapsids for targeting and tracking toward nanotheranostic delivery.
    Stark M; Cheng RH
    Pharm Pat Anal; 2016 Sep; 5(5):307-17. PubMed ID: 27610752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
    Panda SK; Kapur N; Paliwal D; Durgapal H
    J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
    Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes.
    Niikura M; Takamura S; Kim G; Kawai S; Saijo M; Morikawa S; Kurane I; Li TC; Takeda N; Yasutomi Y
    Virology; 2002 Feb; 293(2):273-80. PubMed ID: 11886247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream V105DLP108 Immunoactivity.
    Wang H; Ji F; Liang H; Gu H; Ning Z; Liu R; Zhang G
    PLoS One; 2015; 10(7):e0133282. PubMed ID: 26177202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression, purification and immunogenicity of a novel hepatitis E virus-like particle].
    Dong C; Meng JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):339-42. PubMed ID: 16643795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein.
    Zhang J; Gu Y; Ge SX; Li SW; He ZQ; Huang GY; Zhuang H; Ng MH; Xia NS
    Vaccine; 2005 Apr; 23(22):2881-92. PubMed ID: 15780737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system.
    Kobayashi T; Takahashi M; Tanggis ; Mulyanto ; Jirintai S; Nagashima S; Nishizawa T; Okamoto H
    J Virol Methods; 2016 Jul; 233():78-88. PubMed ID: 26992654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin(®).
    Zhang X; Wei M; Pan H; Lin Z; Wang K; Weng Z; Zhu Y; Xin L; Zhang J; Li S; Xia N; Zhao Q
    Vaccine; 2014 Jul; 32(32):4039-50. PubMed ID: 24892250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.
    Li HZ; Gang HY; Sun QM; Liu X; Ma YB; Sun MS; Dai CB
    Chin Med Sci J; 2004 Jun; 19(2):78-83. PubMed ID: 15250239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.
    Robinson RA; Burgess WH; Emerson SU; Leibowitz RS; Sosnovtseva SA; Tsarev S; Purcell RH
    Protein Expr Purif; 1998 Feb; 12(1):75-84. PubMed ID: 9473460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses.
    Shima R; Li TC; Sendai Y; Kataoka C; Mori Y; Abe T; Takeda N; Okamoto T; Matsuura Y
    Sci Rep; 2016 Feb; 6():21638. PubMed ID: 26905478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of antigenic epitopes of the ORF2 protein from hepatitis E virus genotype 4.
    Zhang H; Dai X; Shan X; Meng J
    Virus Res; 2009 Jun; 142(1-2):140-3. PubMed ID: 19428747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of site-modified nanocapsid with monodispersed gold clusters.
    Stark MC; Baikoghli MA; Lahtinen T; Malola S; Xing L; Nguyen M; Nguyen M; Sikaroudi A; Marjomäki V; Häkkinen H; Cheng RH
    Sci Rep; 2017 Dec; 7(1):17048. PubMed ID: 29213060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.